Digestive Diseases and Sciences

, Volume 49, Issue 11–12, pp 1830–1835 | Cite as

Helicobacter pylori Infection Induces Interleukin-18 Production in Gastric Epithelial (AGS) Cells

  • Andrew S. Day
  • Bin Su
  • Peter J. M. Ceponis
  • Nicola L. Jones
  • Edwin Yau
  • Daniel Sieveking
  • Philip M. ShermanEmail author


Helicobacter pylori colonization of the stomach results in a chronic–active gastritis characterized by mucosal infiltration of both neutrophils and lymphocytes. A T helper lymphocyte (Th1) profile predominates, which promotes the chronic and persistent inflammatory changes in the gastric mucosa in response to this bacterial pathogen. The cytokine interleukin-18 induces production of interferon-γ by activated T lymphocytes and promotes a Th1 profile. An in vitro model system was utilized to determine the role of interleukin-18 in response to infection of gastric epithelial cells by H. pylori. H. pylori isolates, characterized with respect to cagE and cagA and VacA status, were employed to infect AGS gastric epithelial cells. Interleukin-18 production was determined by immunoassay. Infection of AGS cells with H. pylori resulted in a 1.8-fold increase in interleukin-18 compared to uninfected cells (22.7 ± 2.4 vs. 12.7 ± 2.2 pg/ml; P&<0.005). This interleukin-18 response was independent of the cagE status of infecting strains (23.3 ± 1.9 vs. 26.3 ± 3.6 pg/ml; P = NS). Exposure of AGS cells to recombinant interleukin-18 resulted in dose-dependent and time-dependent secretion of interleukin-8 that was maximal following exposure to 100 pg/ml interleukin-18 for 24 hr (292 ± 5 pg/ml, versus 102 ± 14 pg/ml in unstimulated cells; P&<0.001). Interleukin-8 secretion was inhibited following pretreatment of cells with anti-interleukin-18 antibody and by pharmacological inhibition of the nuclear transcription factor, NF-κB. These findings demonstrate that interleukin-18 can enhance host chemokine response to H. pylori infection.

Helicobacter pylori interleukin-18 interleukin-8 epithelium in vitro 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Day AS, Sherman PM: Understanding disease outcome following acquisition of Helicobacter pylori infection during childhood. Can. J. Gastroenterol 13:229–234, 1999CrossRefPubMedGoogle Scholar
  2. 2.
    Blaser MJ, Chyou PH, Nomura A: Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res. 55:562–655, 1995PubMedGoogle Scholar
  3. 3.
    Fennerty MB: Is the only good H. pylori a dead H. pylori? Gastroenterology 111:1773–1774, 1996.CrossRefPubMedGoogle Scholar
  4. 4.
    Crabtree JE: Virulence factors of H. pylori and their effect on chemokine production. In The Immunobiology of H. pylori. Ernst PB, Michetti P, Smith PD (eds). Philadelphia, Lippincott–Raven, Philadelphia 1999, pp 101–112Google Scholar
  5. 5.
    Day AS, Jones NL, Lynett JT, Jennings HA, Fallone CA, Beech R, Sherman PM: cagE is a virulence factor associated with duodenal ulceration in Helicobacter pylori infection in children. J Infect Dis 181:1370–1375, 2000CrossRefPubMedGoogle Scholar
  6. 6.
    Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R, Covacci A: cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 93:14648–14653, 1996CrossRefPubMedGoogle Scholar
  7. 7.
    Crabtree JE: Role of cytokines in pathogenesis of Helicobacter pylori-induced mucosal damage. Dig Dis Sci 43(Suppl 9):46S–55S, 1998PubMedGoogle Scholar
  8. 8.
    Takagi A, Kamiya S, Koga Y, Ohta U, Kobayashi H, Shirai T, Harsawa S, Miwa T: Analysis of interleukin-8 secretion induced by Helicobacter pylori from the gastric epithelial cell line MKN45: A mechanism independent of the intensity of cytotoxicity. J Gastroenterol Hepatol 12:368–372, 1997CrossRefPubMedGoogle Scholar
  9. 9.
    Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm AM: Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 66:5964–5971, 1998PubMedPubMedCentralGoogle Scholar
  10. 10.
    Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J: Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 41:442–451, 1997CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Dinarello CA: IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 103:11–24, 1999CrossRefGoogle Scholar
  12. 12.
    Takeuchi M, Nishizaki Y, Sano O, Ohta T, Ikeda M, Kurimoto M: Immunohistochemical and immuno-electron-microscopic detection of interferon-gamma-inducing factor (“interleukin-18”) in mouse intestinal epithelial cells. Cell Tissue Res 289:499–503, 1997CrossRefPubMedGoogle Scholar
  13. 13.
    Crowe SE, Alvarez L, Dytoc M, Hunt RH, Muller M, Sherman PM, Patel J, Jin Y, Ernst PB: Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology 108:65–74, 1995CrossRefPubMedGoogle Scholar
  14. 14.
    D’Elios M, Manghetti M, De Carli M, Costa F, Baldari CT, Burroni D, Telford JL, Romagnani S, Del Prete G: T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 158:962–967, 1997PubMedGoogle Scholar
  15. 15.
    Hatz R, Meimarakis G, Bayerdorffer E, Stolte M, Kirchner T, Enders G: Characterisation of lymphocytic infiltrates in Helicobacter pylori associated gastritis. Scand J Gastroenterol 31:222–228, 1996CrossRefPubMedGoogle Scholar
  16. 16.
    Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI: Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 32:1473–1477, 1991CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Mohammadi M, Czinn S, Redline R, Nedrud J: Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J Immunol 156:4729–4738, 1996PubMedGoogle Scholar
  18. 18.
    Monteleone G, Trapasso F, Parrello T, Biancone L, Stella A, Iuliano R, Luzza F, Fusco A, Pallone F: Bioactive IL-18 expression is up-regulated in Crohn’s disease. J Immunol 163:143–147, 1999PubMedGoogle Scholar
  19. 19.
    Pizarro TT, Michie MH, Bentz M, Woraratanadharm J, Smith MF Jr, Foley E, Moskaluk CA, Bickston SJ, Cominelli F: IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn’s disease: Expression and localization in intestinal mucosal cells. J Immunol 162:6829–6835, 1999PubMedGoogle Scholar
  20. 20.
    Tomita T, Jackson AM, Hida N, Hayat M, Dixon MF, Shimoyama T, Axon AT, Robinson PA, Crabtree JE: Expression of interleukin-18, a Th1 cytokine, in human gastric mucosa is increased in Helicobacter pylori infection. J Infect Dis 183:620–627, 2001CrossRefPubMedGoogle Scholar
  21. 21.
    Tanahashi T, Kita M, Kodama T, Yamaoka Y, Sawai N, Ohno T, Mitsufuji S, Wei YP, Kashima K, Imanishi J. Cytokine expression and production by purified Helicobacter pylori urease in human gastric epithelial cells. Infect Immun 68:664–671, 2000CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Akira S: The role of IL-18 in innate immunity. Curr Opin Immunol 12:59–63, 2000CrossRefPubMedGoogle Scholar
  23. 23.
    Mastroeni P, Clare S, Khan S, Harrison JA, Hormaeche CE, Okamura H, Kurimoto M, Dougan G: Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with Salmonella typhimurium. Infect Immun 67:478–483, 1999PubMedPubMedCentralGoogle Scholar
  24. 24.
    Hochholzer P, Lipford GB, Wagner H, Pfeffer K, Heeg K: Role of interleukin-18 (IL-18) during lethal shock: Decreased lipopolysaccharide sensitivity but normal superantigen reaction in IL-18-deficient mice. Infect Immun 68:3502–3508, 2000CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Okhusu K, Yoshimoto T, Takeda K, Ogura T, Kashiwamura S, Iwakura Y, Akira S, Okamura H, Nakanishi K: Potentiality of interleukin-18 as a useful reagent for treatment and prevention of Leishmania major infection. Infect Immun 68:2449–2456, 2000CrossRefGoogle Scholar
  26. 26.
    Airoldi I, Gri G, Marshall JD, Corcione A, Facchetti P, Guglielmino R, Trinchieri G, Pistoia V: Expression and function of IL-12 and IL-18 receptors on human tonsillar B cells. J Immunol 165:6880–6888, 2000CrossRefPubMedGoogle Scholar
  27. 27.
    Kojima H, Aizawa Y, Yanai Y, Nagaoka K, Takeuchi M, Ohta T, Ikegami H, Ikeda M, Kurimoto M: An essential role for NF-kappaB in IL-18-induced INF-gamma expression in KG-1 cells. J Immunol 162:5063–5069, 1999PubMedGoogle Scholar
  28. 28.
    Shapiro L, Puren AJ, Barton HA, Novick D, Peskind RL, Shenkar R, Gu Y, Su MS, Dinarello CA: Interleukin 18 stimulates HIV type 1 in monocytic cells. Proc Natl Acad Sci USA 95:12550–12555, 1998CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2004

Authors and Affiliations

  • Andrew S. Day
    • 2
  • Bin Su
    • 1
  • Peter J. M. Ceponis
    • 1
  • Nicola L. Jones
    • 1
  • Edwin Yau
    • 1
  • Daniel Sieveking
    • 2
  • Philip M. Sherman
    • 2
    Email author
  1. 1.Research Institute, Hospital for Sick Children; Departments of Paediatrics, Physiology and Laboratory Medicine & PathobiologyUniversity of TorontoTorontoCanada
  2. 2.Sydney Children’s Hospital and School of Women’s and Children’s HealthUniversity of New South WalesSydneyAustralia

Personalised recommendations